80.41  2.16 (2.76%)		07-28 10:44
Open: 79.1 High: 81.131 Volume: 104,899		Pre. Close: 78.25 Low: 78.25 Market Cap: 10,844(M)

Short term
Mid term
Targets	6-month :	100.84	1-year :	117.78
Resists	First :	86.33	Second :	100.84
Pivot price	77.4
Supports	First :	78.95	Second :	74.38
MAs	MA(5) :	77.2	MA(20) :	77.77
	MA(100) :	83.87	MA(250) :	78.56
MACD	MACD :	-0.8	Signal :	-1
%K %D	K(14,3) :	53	D(3) :	34
RSI	RSI(14): 54
52-week	High :	101.4	Low :	51.79

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ GMED ] has closed below upper band by 7.7%. Bollinger Bands are 40.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	79.02 - 79.33	79.33 - 79.68
Low:	74.91 - 75.23	75.23 - 75.6
Close:	77.64 - 78.17	78.17 - 78.77

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.

Mon, 27 Jul 2026
Globus Medical Inc (GMED) Balance Sheet - TradingKey

Mon, 27 Jul 2026
GMED|Globus Medical Inc|Price:78.225|Chg%:+1.735 - TradingKey

Fri, 24 Jul 2026
GMED|Globus Medical Inc|Price:78.225|Chg%:+1.735 - TradingKey

Thu, 23 Jul 2026
GMED Growth Drivers After NuVasive and What Q1 Signals - qz.com

Wed, 22 Jul 2026
Reasons to Retain Globus Medical Stock in Your Portfolio for Now - TradingView

Thu, 16 Jul 2026
Globus Medical to Announce Second Quarter 2026 Financial Results on August 6 - Quiver Quantitative

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Devices
Shares Out	113 (M)
Shares Float	112 (M)
Held by Insiders	0.7 (%)
Held by Institutions	102 (%)
Shares Short	7,070 (K)
Shares Short P.Month	5,470 (K)

EPS	4.28
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	34.88
Profit Margin	18.9 %
Operating Margin	21.3 %
Return on Assets (ttm)	8.1 %
Return on Equity (ttm)	13.3 %
Qtrly Rev. Growth	27 %
Gross Profit (p.s.)	18.7
Sales Per Share	27.35
EBITDA (p.s.)	8.34
Qtrly Earnings Growth	66.6 %
Operating Cash Flow	779 (M)
Levered Free Cash Flow	341 (M)

PE Ratio	18.77
PEG Ratio	1.4
Price to Book value	2.3
Price to Sales	2.93
Price to Cash Flow	11.69

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.